Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
LabVantage Solutions announced the appointment of Mikael Hagstroem as Chief Executive Officer.
read more
SignalChem Lifesciences announces a collaboration with Merck to evaluate the combination of SLC-391, a selective AXL inhibitor developed by SignalChem, with KEYTRUDA, Merck’s anti-PD-1 therapy, in patients with advanced non-small cell lung cancer.
read more
Wednesday, March 31, 2021
Perigord announced Tech Mahindra has acquired a 70% stake in Perigord Life Science Solutions, a digital workflow and artwork, labelling and BPO services firm.
read more
Wednesday, March 31, 2021
Crystec are pleased to announce the opening of a new subsidiary, Nantong Crystec Pharmaceutical R&D Co. Ltd., and research facility, located at Haimen Science and Technology Park in Haimen City, Jiangsu Province, China.
read more
Wednesday, March 31, 2021
INTEGRA Biosciences celebrated the expansion of its state-of-the-art facility in Hudson, NH, with a community ribbon cutting ceremony.
read more
Wednesday, March 31, 2021
Albumedix announced they have entered into a distribution agreement with established and well recognized reagent supplier FUJIFILM Wako.
read more
Wednesday, March 31, 2021
TCR2 Therapeutics has signed a long-term, full-building lease with Alexandria Real Estate Equities for an existing 85,000 square foot cell therapy manufacturing facility in Rockville, Maryland.
read more
Wednesday, March 31, 2021
Ajinomoto and Bright Peak Therapeutics announced a research collaboration and exclusive license agreement to incorporate AJICAP, Ajinomoto’s proprietary site-specific bioconjugation technology.
read more
Wednesday, March 31, 2021
Asymchem has announced a dedicated expansion of API manufacturing facilities to provide clients with peptide and oligonucleotide products.
read more
RenovaCare announced its Chairman, Chief Executive Officer, and President, Alan Rubino, has decided to retire.
read more
HUYABIO has entered into a clinical collaboration agreement with Bristol-Myers Squibb to evaluate the combination of HUYABIO's HBI-8000.
read more
Moderna has announced the Company has shipped the 100-millionth dose of its COVID-19 vaccine to the U.S. Government.
read more
Ovid announced the closing of the Royalty, License and Termination agreement under which Takeda secured global rights from Ovid to develop and commercialize soticlestat.
read more
Viroclinics-DDL and ENPICOM announced the approval of their joint MIT Zuid subsidy (SME Innovation Stimulation Top Sectors South Holland) application.
read more
GRAM announced that the company was recently audited by the Dutch Health and Youth Care Inspectorate and issued EU GMP certificate.
read more